Atlas Trials

Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas

Clinical trial NCT06311032 · COMPLETED

Trial details

NCT number
NCT06311032
Sponsor
NYU Langone Health
Status
COMPLETED
Study type
OBSERVATIONAL
Surgery Risk Assessment
Start date
2023-03-29
Primary completion
2023-06-28
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.